| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | recombination hotspot binding | 4.47e-05 | 2 | 134 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | small GTPase binding | DOCK1 FLNA RIN3 DOCK9 DOCK5 RANBP17 ARHGDIB DENND5A MLPH RIC1 | 6.29e-05 | 321 | 134 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | DOCK1 FLNA RIN3 DOCK9 DOCK5 RANBP17 ARHGDIB DENND5A MLPH RIC1 | 1.61e-04 | 360 | 134 | 10 | GO:0051020 |
| GeneOntologyCellularComponent | CHD-type complex | 3.50e-06 | 17 | 133 | 4 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 3.50e-06 | 17 | 133 | 4 | GO:0016581 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 2.06e-05 | 9 | 133 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 8.71e-05 | 14 | 133 | 3 | GO:0072379 | |
| Domain | CHD_N | 3.45e-07 | 3 | 132 | 3 | IPR012958 | |
| Domain | CHD_C2 | 3.45e-07 | 3 | 132 | 3 | IPR012957 | |
| Domain | CHDCT2 | 3.45e-07 | 3 | 132 | 3 | PF08074 | |
| Domain | CHDNT | 3.45e-07 | 3 | 132 | 3 | PF08073 | |
| Domain | DUF1086 | 3.45e-07 | 3 | 132 | 3 | IPR009462 | |
| Domain | DUF1087 | 3.45e-07 | 3 | 132 | 3 | IPR009463 | |
| Domain | DUF1087 | 3.45e-07 | 3 | 132 | 3 | PF06465 | |
| Domain | DUF1086 | 3.45e-07 | 3 | 132 | 3 | PF06461 | |
| Domain | DUF1087 | 3.45e-07 | 3 | 132 | 3 | SM01147 | |
| Domain | DUF1086 | 3.45e-07 | 3 | 132 | 3 | SM01146 | |
| Domain | DUF2012 | 1.37e-06 | 4 | 132 | 3 | PF09430 | |
| Domain | DUF2012 | 1.37e-06 | 4 | 132 | 3 | IPR019008 | |
| Domain | CarboxyPept-like_regulatory | 5.28e-06 | 17 | 132 | 4 | IPR008969 | |
| Domain | Carb-bd-like_fold | 1.88e-05 | 8 | 132 | 3 | IPR013784 | |
| Domain | DHR-1_domain | 5.46e-05 | 11 | 132 | 3 | IPR027007 | |
| Domain | DHR_2 | 5.46e-05 | 11 | 132 | 3 | PS51651 | |
| Domain | DHR_1 | 5.46e-05 | 11 | 132 | 3 | PS51650 | |
| Domain | DHR-2 | 5.46e-05 | 11 | 132 | 3 | PF06920 | |
| Domain | DOCK | 5.46e-05 | 11 | 132 | 3 | IPR026791 | |
| Domain | DOCK_C | 5.46e-05 | 11 | 132 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 5.46e-05 | 11 | 132 | 3 | PF14429 | |
| Domain | DHR-2 | 5.46e-05 | 11 | 132 | 3 | IPR027357 | |
| Domain | CarboxyPept_regulatory_dom | 9.37e-05 | 13 | 132 | 3 | IPR014766 | |
| Domain | - | 9.37e-05 | 13 | 132 | 3 | 2.60.40.1120 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.05e-04 | 35 | 132 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.46e-04 | 38 | 132 | 4 | PS00690 | |
| Domain | DOCK_N | 4.89e-04 | 5 | 132 | 2 | PF16172 | |
| Domain | DOCK_N | 4.89e-04 | 5 | 132 | 2 | IPR032376 | |
| Domain | Chromo_domain | 6.26e-04 | 24 | 132 | 3 | IPR023780 | |
| Domain | Chromo | 7.97e-04 | 26 | 132 | 3 | PF00385 | |
| Domain | Helicase_C | 9.76e-04 | 107 | 132 | 5 | PF00271 | |
| Domain | HELICc | 9.76e-04 | 107 | 132 | 5 | SM00490 | |
| Domain | CHROMO_1 | 9.93e-04 | 28 | 132 | 3 | PS00598 | |
| Domain | CHROMO_2 | 9.93e-04 | 28 | 132 | 3 | PS50013 | |
| Domain | Helicase_C | 1.02e-03 | 108 | 132 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.06e-03 | 109 | 132 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.06e-03 | 109 | 132 | 5 | PS51192 | |
| Domain | PH | 1.23e-03 | 229 | 132 | 7 | PF00169 | |
| Domain | SSXRD | 1.35e-03 | 8 | 132 | 2 | PF09514 | |
| Domain | SSXRD_motif | 1.35e-03 | 8 | 132 | 2 | IPR019041 | |
| Domain | SNF2_N | 1.47e-03 | 32 | 132 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.47e-03 | 32 | 132 | 3 | PF00176 | |
| Domain | Chromodomain-like | 1.47e-03 | 32 | 132 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.61e-03 | 33 | 132 | 3 | IPR000953 | |
| Domain | CHROMO | 1.61e-03 | 33 | 132 | 3 | SM00298 | |
| Domain | DAGK_acc | 2.15e-03 | 10 | 132 | 2 | PF00609 | |
| Domain | IG_FLMN | 2.15e-03 | 10 | 132 | 2 | SM00557 | |
| Domain | Diacylglycerol_kin_accessory | 2.15e-03 | 10 | 132 | 2 | IPR000756 | |
| Domain | DAGKa | 2.15e-03 | 10 | 132 | 2 | SM00045 | |
| Domain | Filamin | 2.62e-03 | 11 | 132 | 2 | PF00630 | |
| Domain | KRAB_RELATED | 2.62e-03 | 11 | 132 | 2 | PS50806 | |
| Domain | FILAMIN_REPEAT | 2.62e-03 | 11 | 132 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.62e-03 | 11 | 132 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.62e-03 | 11 | 132 | 2 | IPR017868 | |
| Domain | WWE | 3.12e-03 | 12 | 132 | 2 | PF02825 | |
| Domain | WWE-dom | 3.12e-03 | 12 | 132 | 2 | IPR004170 | |
| Domain | WWE | 3.12e-03 | 12 | 132 | 2 | PS50918 | |
| Domain | PH | 3.65e-03 | 278 | 132 | 7 | SM00233 | |
| Domain | Krueppel-associated_box-rel | 3.67e-03 | 13 | 132 | 2 | IPR003655 | |
| Domain | PH_DOMAIN | 3.72e-03 | 279 | 132 | 7 | PS50003 | |
| Domain | PH_domain | 3.79e-03 | 280 | 132 | 7 | IPR001849 | |
| Domain | DAGKc | 4.27e-03 | 14 | 132 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 4.90e-03 | 15 | 132 | 2 | IPR001206 | |
| Domain | DAGK | 4.90e-03 | 15 | 132 | 2 | PS50146 | |
| Domain | DAGK_cat | 4.90e-03 | 15 | 132 | 2 | PF00781 | |
| Domain | TPR_2 | 5.31e-03 | 50 | 132 | 3 | PF07719 | |
| Domain | TPR_2 | 5.31e-03 | 50 | 132 | 3 | IPR013105 | |
| Domain | NAD/diacylglycerol_kinase | 6.29e-03 | 17 | 132 | 2 | IPR016064 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATG101 IL31RA RBL1 NLRX1 RIPK2 TTC14 MYO1B CHD4 NOMO1 SGK3 FZR1 DST NOMO2 CTR9 NRK PIP4K2A WDR82 EIF3D NOMO3 HDAC2 | 4.10e-10 | 910 | 135 | 20 | 36736316 |
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 5.72e-08 | 3 | 135 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.28e-07 | 4 | 135 | 3 | 31833031 | |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 9267806 | ||
| Pubmed | 4.97e-07 | 17 | 135 | 4 | 27806305 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA SRSF10 PMPCB DHX37 AZGP1 NOC3L MYO1B DGKD CHD4 HUWE1 PHLDB1 DST PSME4 CTR9 SUPV3L1 PIP4K2A WDR82 EIF3D PHLDB2 | 1.28e-06 | 1353 | 135 | 19 | 29467282 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA RIN3 DOCK9 NLRX1 LAMC3 HUWE1 ARHGAP35 FZR1 PHLDB1 DST PSME4 SH3TC1 CHD5 COBL UNKL DENND5A RIC1 | 1.45e-06 | 1105 | 135 | 17 | 35748872 |
| Pubmed | 2.97e-06 | 225 | 135 | 8 | 12168954 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 3.16e-06 | 8 | 135 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 4.72e-06 | 9 | 135 | 3 | 36261522 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 SLC25A42 ANXA4 SH3BP2 TTC14 DGKH CHD3 HUWE1 ARHGAP35 CPT1A DOCK5 RANBP17 PHLDB1 SH3TC1 COBL DENND5A MLPH ADGRD1 RIC1 | 5.15e-06 | 1489 | 135 | 19 | 28611215 |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 9.22e-06 | 11 | 135 | 3 | 10204490 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 9.22e-06 | 11 | 135 | 3 | 32820719 | |
| Pubmed | ZNF143 RBL1 DHX37 CHD3 DOCK5 DST PSME4 CTR9 SUPV3L1 DENND5A RIC1 WDR48 | 9.39e-06 | 650 | 135 | 12 | 38777146 | |
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 21743469 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 9885572 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 22560079 | ||
| Pubmed | FLNA SRSF10 PMPCB NOC3L KRBA2 MYO1B CHD3 CHD4 STOX1 MEN1 DST CTR9 CHD5 PIP4K2A CEP83 GPR171 MLPH HDAC2 | 1.26e-05 | 1442 | 135 | 18 | 35575683 | |
| Pubmed | 1.45e-05 | 38 | 135 | 4 | 33283408 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20513769 | ||
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 1.50e-05 | 2 | 135 | 2 | 7560064 | |
| Pubmed | Identification and characterization of two splice variants of human diacylglycerol kinase eta. | 1.50e-05 | 2 | 135 | 2 | 12810723 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16891417 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 7575689 | ||
| Pubmed | Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. | 1.50e-05 | 2 | 135 | 2 | 19509238 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27485544 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9654129 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26821013 | ||
| Pubmed | A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature. | 1.50e-05 | 2 | 135 | 2 | 18036394 | |
| Pubmed | An adventitious interaction of filamin A with RhoGDI2(Tyr153Glu). | 1.50e-05 | 2 | 135 | 2 | 26707877 | |
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 1.50e-05 | 2 | 135 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 1.50e-05 | 2 | 135 | 2 | 8843877 | |
| Pubmed | LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. | 1.59e-05 | 13 | 135 | 3 | 19703393 | |
| Pubmed | 1.66e-05 | 285 | 135 | 8 | 34369648 | ||
| Pubmed | 2.02e-05 | 14 | 135 | 3 | 16428440 | ||
| Pubmed | NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. | 2.02e-05 | 14 | 135 | 3 | 25150861 | |
| Pubmed | 2.02e-05 | 14 | 135 | 3 | 12432077 | ||
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 2.52e-05 | 15 | 135 | 3 | 35695185 | |
| Pubmed | The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1. | 2.52e-05 | 15 | 135 | 3 | 25247294 | |
| Pubmed | Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. | 2.52e-05 | 15 | 135 | 3 | 9804427 | |
| Pubmed | NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. | 2.52e-05 | 15 | 135 | 3 | 19927129 | |
| Pubmed | 2.52e-05 | 15 | 135 | 3 | 6696991 | ||
| Pubmed | 2.86e-05 | 45 | 135 | 4 | 22114352 | ||
| Pubmed | RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. | 3.09e-05 | 16 | 135 | 3 | 30760870 | |
| Pubmed | 3.40e-05 | 513 | 135 | 10 | 25798074 | ||
| Pubmed | 3.96e-05 | 418 | 135 | 9 | 34709266 | ||
| Pubmed | 4.47e-05 | 18 | 135 | 3 | 9790534 | ||
| Pubmed | 4.47e-05 | 18 | 135 | 3 | 12493763 | ||
| Pubmed | 4.47e-05 | 18 | 135 | 3 | 10444591 | ||
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 4.47e-05 | 18 | 135 | 3 | 19497860 | |
| Pubmed | Doublefoot: a new mouse mutant affecting development of limbs and head. | 4.48e-05 | 3 | 135 | 2 | 9062079 | |
| Pubmed | The Dictyostelium discoideum family of Rho-related proteins. | 4.48e-05 | 3 | 135 | 2 | 11222756 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18258202 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 32464244 | ||
| Pubmed | Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis. | 4.48e-05 | 3 | 135 | 2 | 27314390 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23949095 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 2159965 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 32658897 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19802015 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 12426103 | ||
| Pubmed | Role of melanocyte morphology in pigmentation of mouse hair. | 4.48e-05 | 3 | 135 | 2 | 5726144 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 35468874 | ||
| Pubmed | Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response. | 4.48e-05 | 3 | 135 | 2 | 11602572 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 20236936 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23093722 | ||
| Pubmed | The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. | 4.48e-05 | 3 | 135 | 2 | 22212556 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 4.71e-05 | 330 | 135 | 8 | 33301849 | |
| Pubmed | BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein. | 7.31e-05 | 57 | 135 | 4 | 27433848 | |
| Pubmed | FLNA SRSF10 DOCK9 SPCS2 TTC14 CHD3 HUWE1 MEN1 TBCCD1 HAVCR1 PSME4 CTR9 LRP2 SPTY2D1 | 8.66e-05 | 1084 | 135 | 14 | 11544199 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 22016339 | ||
| Pubmed | DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV. | 8.93e-05 | 4 | 135 | 2 | 19004829 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 23362269 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 34741163 | ||
| Pubmed | Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport. | 8.93e-05 | 4 | 135 | 2 | 28738127 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 16574654 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 22771033 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 9326634 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 12431981 | ||
| Pubmed | The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo. | 8.93e-05 | 4 | 135 | 2 | 18820033 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 24982445 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 30818224 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 14779004 | ||
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 8.93e-05 | 4 | 135 | 2 | 18231586 | |
| Pubmed | 1.02e-04 | 62 | 135 | 4 | 15862967 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | ATG101 RIN3 RBL1 ANXA4 ZFP28 DGKD CHD3 ABHD4 ARHGDIB ERG28 NOMO2 WDR82 EIF3D DENND5A | 1.27e-04 | 1124 | 135 | 14 | 21900206 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA SRSF10 DHX37 AZGP1 NOC3L TTC14 MYO1B CHD4 HUWE1 CTR9 EIF3D SPTY2D1 HDAC2 | 1.32e-04 | 989 | 135 | 13 | 36424410 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA SRSF10 PMPCB DHX37 AZGP1 NOC3L MYO1B LAMC3 CHD4 HUWE1 PRDM7 NOMO1 CTR9 SUPV3L1 KIF14 EIF3D | 1.36e-04 | 1425 | 135 | 16 | 30948266 |
| Pubmed | 1.48e-04 | 5 | 135 | 2 | 18835386 | ||
| Pubmed | The leaden gene product is required with Rab27a to recruit myosin Va to melanosomes in melanocytes. | 1.48e-04 | 5 | 135 | 2 | 11886590 | |
| Pubmed | Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. | 1.48e-04 | 5 | 135 | 2 | 17922035 | |
| Pubmed | 1.48e-04 | 5 | 135 | 2 | 24365888 | ||
| Pubmed | Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity. | 1.48e-04 | 5 | 135 | 2 | 38878769 | |
| Pubmed | 1.48e-04 | 5 | 135 | 2 | 23940118 | ||
| Pubmed | 1.48e-04 | 5 | 135 | 2 | 14559791 | ||
| Pubmed | Close linkage of the dominant cataract mutations (Cat-2) with Idh-1 and cryge on mouse chromosome 1. | 1.48e-04 | 5 | 135 | 2 | 7829079 | |
| Pubmed | 1.48e-04 | 5 | 135 | 2 | 22457607 | ||
| Pubmed | Position on mouse chromosome 1 of a gene that controls resistance to Salmonella typhimurium. | 1.48e-04 | 5 | 135 | 2 | 7047397 | |
| Pubmed | 1.48e-04 | 5 | 135 | 2 | 18644863 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.54e-04 | 69 | 135 | 4 | 28481362 | |
| Interaction | CSNK2A3 interactions | 6.40e-07 | 110 | 132 | 8 | int:CSNK2A3 | |
| Interaction | CPSF2 interactions | 2.11e-06 | 173 | 132 | 9 | int:CPSF2 | |
| Interaction | NCLN interactions | 3.35e-06 | 183 | 132 | 9 | int:NCLN | |
| Interaction | SUDS3 interactions | 4.17e-06 | 141 | 132 | 8 | int:SUDS3 | |
| Interaction | MTA3 interactions | 1.87e-05 | 173 | 132 | 8 | int:MTA3 | |
| Interaction | TBL3 interactions | 2.30e-05 | 178 | 132 | 8 | int:TBL3 | |
| Interaction | PPP1R10 interactions | 2.39e-05 | 179 | 132 | 8 | int:PPP1R10 | |
| Interaction | TNFAIP6 interactions | 2.75e-05 | 27 | 132 | 4 | int:TNFAIP6 | |
| Interaction | RBM10 interactions | 4.45e-05 | 253 | 132 | 9 | int:RBM10 | |
| Interaction | BACC1 interactions | 6.32e-05 | 104 | 132 | 6 | int:BACC1 | |
| Interaction | CSNK2A2 interactions | GPR137 RBL1 AZGP1 LAMC3 CHD4 HUWE1 TIPARP MEN1 CTR9 PIP4K2A KIF14 WDR82 EIF3D HDAC2 WDR48 | 7.38e-05 | 718 | 132 | 15 | int:CSNK2A2 |
| Interaction | PRPF4 interactions | 7.56e-05 | 271 | 132 | 9 | int:PRPF4 | |
| GeneFamily | PHD finger proteins|NuRD complex | 2.88e-07 | 12 | 91 | 4 | 1305 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.11e-05 | 206 | 91 | 7 | 682 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.10e-03 | 10 | 91 | 2 | 1178 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-08 | 200 | 135 | 9 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.33e-07 | 192 | 135 | 8 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 195 | 135 | 8 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.55e-07 | 196 | 135 | 8 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 1.58e-06 | 185 | 135 | 7 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.58e-06 | 185 | 135 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 186 | 135 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 189 | 135 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.88e-06 | 190 | 135 | 7 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-06 | 193 | 135 | 7 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 194 | 135 | 7 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | 343B|World / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-06 | 195 | 135 | 7 | 2290911fde6efacfa38b985a2541322968bee42d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 195 | 135 | 7 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 135 | 7 | 82b117be41f2e7d677a42d2a5198726eeccb16d0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 135 | 7 | 83aeb96a33802949238d8a097086a1812201d1b5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-06 | 197 | 135 | 7 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-06 | 197 | 135 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-06 | 197 | 135 | 7 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-06 | 198 | 135 | 7 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-06 | 198 | 135 | 7 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 199 | 135 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 199 | 135 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 199 | 135 | 7 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 199 | 135 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.56e-06 | 199 | 135 | 7 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-06 | 158 | 135 | 6 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-06 | 158 | 135 | 6 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.34e-05 | 170 | 135 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 175 | 135 | 6 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 175 | 135 | 6 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 179 | 135 | 6 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 180 | 135 | 6 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.97e-05 | 182 | 135 | 6 | 9d727ab84da8de33f1021b492c90d8b4c2a8ea23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 184 | 135 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 184 | 135 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 184 | 135 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.22e-05 | 186 | 135 | 6 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.22e-05 | 186 | 135 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.29e-05 | 187 | 135 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 187 | 135 | 6 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 187 | 135 | 6 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 187 | 135 | 6 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.36e-05 | 188 | 135 | 6 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.43e-05 | 189 | 135 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 189 | 135 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.51e-05 | 190 | 135 | 6 | b47472dc9fe6ed99c2365203a3d8a59879e74a70 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 192 | 135 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 192 | 135 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.66e-05 | 192 | 135 | 6 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.66e-05 | 192 | 135 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.66e-05 | 192 | 135 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-05 | 193 | 135 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-05 | 193 | 135 | 6 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | COVID-19-Epithelial-AT2,_AT1_cells|Epithelial / Condition, Lineage and Cell class | 2.74e-05 | 193 | 135 | 6 | fdebd4a13c189e20638c7d5b351327c33dd36380 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 194 | 135 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-05 | 194 | 135 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.82e-05 | 194 | 135 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | AT2|World / shred by cell class for parenchyma | 2.82e-05 | 194 | 135 | 6 | e773f5ef3abce7113a6b7cc7cbe68de873d4a17f | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 2.82e-05 | 194 | 135 | 6 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 194 | 135 | 6 | 0db439a544cf8f918a77058fd70319ab0e8e645e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 195 | 135 | 6 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 195 | 135 | 6 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 195 | 135 | 6 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 195 | 135 | 6 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.98e-05 | 196 | 135 | 6 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 196 | 135 | 6 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-05 | 196 | 135 | 6 | 006d783a530aa6e1e6545dcc2e6b00bb300fe070 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 197 | 135 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 197 | 135 | 6 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.16e-05 | 198 | 135 | 6 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.16e-05 | 198 | 135 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.16e-05 | 198 | 135 | 6 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.16e-05 | 198 | 135 | 6 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.16e-05 | 198 | 135 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.16e-05 | 198 | 135 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 199 | 135 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.25e-05 | 199 | 135 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 199 | 135 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 199 | 135 | 6 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-05 | 199 | 135 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 3.25e-05 | 199 | 135 | 6 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-05 | 200 | 135 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-05 | 200 | 135 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 152 | 135 | 5 | cefc0ab592e99badf145fb95adf9906cb81be81c | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 152 | 135 | 5 | c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 152 | 135 | 5 | c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 158 | 135 | 5 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 163 | 135 | 5 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 164 | 135 | 5 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 164 | 135 | 5 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 164 | 135 | 5 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.52e-04 | 166 | 135 | 5 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | Ionocyte-iono-3|World / Class top | 1.52e-04 | 166 | 135 | 5 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-04 | 167 | 135 | 5 | fd84a99ea142d1684cdcf4a88ef1d541760bc78a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.60e-04 | 168 | 135 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| Disease | cutaneous squamous cell carcinoma | 1.25e-05 | 33 | 128 | 4 | EFO_1001927 | |
| Disease | Ankylosing spondylitis | 1.28e-05 | 11 | 128 | 3 | C0038013 | |
| Disease | developmental and epileptic encephalopathy 64 (implicated_via_orthology) | 1.87e-05 | 2 | 128 | 2 | DOID:0070375 (implicated_via_orthology) | |
| Disease | kidney failure (implicated_via_orthology) | 1.85e-04 | 5 | 128 | 2 | DOID:1074 (implicated_via_orthology) | |
| Disease | vesicoureteral reflux (is_marker_for) | 1.85e-04 | 5 | 128 | 2 | DOID:9620 (is_marker_for) | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 2.41e-04 | 28 | 128 | 3 | DOID:784 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.54e-04 | 301 | 128 | 7 | DOID:684 (is_marker_for) | |
| Disease | urate measurement, bone density | PMPCB DGKD TENM2 TIPARP DOCK5 RANBP17 RHOBTB1 RHOBTB2 CEP83 KIF14 | 3.80e-04 | 619 | 128 | 10 | EFO_0003923, EFO_0004531 |
| Disease | response to 5-fluorouracil, response to antineoplastic agent | 3.87e-04 | 7 | 128 | 2 | GO_0036275, GO_0097327 | |
| Disease | chronic hepatitis C virus infection | 3.96e-04 | 33 | 128 | 3 | EFO_0004220 | |
| Disease | beverage consumption measurement | 4.76e-04 | 83 | 128 | 4 | EFO_0010088 | |
| Disease | melanoma | 7.66e-04 | 248 | 128 | 6 | C0025202 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.41e-03 | 13 | 128 | 2 | C3501611 | |
| Disease | Hypothermia, natural | 1.64e-03 | 14 | 128 | 2 | C0020672 | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 2.15e-03 | 16 | 128 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | acute kidney failure (is_marker_for) | 2.43e-03 | 17 | 128 | 2 | DOID:3021 (is_marker_for) | |
| Disease | adenosine monophosphate measurement | 2.73e-03 | 18 | 128 | 2 | EFO_0010454 | |
| Disease | ovarian neoplasm | 2.81e-03 | 134 | 128 | 4 | C0919267 | |
| Disease | age-related hearing impairment | 2.96e-03 | 324 | 128 | 6 | EFO_0005782 | |
| Disease | Malignant neoplasm of ovary | 3.04e-03 | 137 | 128 | 4 | C1140680 | |
| Disease | Pseudopelade | 3.04e-03 | 19 | 128 | 2 | C0086873 | |
| Disease | body weight | DOCK1 GPR137 ZNF143 AZGP1 RIPK2 DGKH HUWE1 CADM2 LDB2 SGK3 CBLN4 ACAN PIP4K2A | 3.34e-03 | 1261 | 128 | 13 | EFO_0004338 |
| Disease | chronic kidney disease (is_marker_for) | 3.37e-03 | 20 | 128 | 2 | DOID:784 (is_marker_for) | |
| Disease | leprosy, Crohn's disease | 3.37e-03 | 20 | 128 | 2 | EFO_0000384, EFO_0001054 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 3.37e-03 | 20 | 128 | 2 | DOID:3328 (is_marker_for) | |
| Disease | sphingomyelin 16:0 measurement | 3.37e-03 | 20 | 128 | 2 | EFO_0010391 | |
| Disease | Adenocarcinoma of prostate | 3.37e-03 | 20 | 128 | 2 | C0007112 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 3.37e-03 | 20 | 128 | 2 | DOID:2986 (is_marker_for) | |
| Disease | Malignant Glioma | 3.53e-03 | 70 | 128 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.53e-03 | 70 | 128 | 3 | C0259783 | |
| Disease | estrogen-receptor negative breast cancer | 3.68e-03 | 71 | 128 | 3 | EFO_1000650 | |
| Disease | Osteogenesis imperfecta | 3.71e-03 | 21 | 128 | 2 | cv:C0029434 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.01e-03 | 148 | 128 | 4 | C0279702 | |
| Disease | nephrosis (biomarker_via_orthology) | 4.07e-03 | 22 | 128 | 2 | DOID:2527 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRLVLYFKSGKYSTF | 36 | Q9BXU7 | |
| YRTQKFGKLDYTSGH | 121 | Q6UWY0 | |
| AIHGSKDKRSYEALY | 136 | Q8N1A6 | |
| YTGFHLEYKAKLRES | 1686 | Q7Z407 | |
| IVFLYSLYKEGHSKG | 736 | Q8TDI0 | |
| VIKVFGSEDSKHRYY | 661 | Q6QNK2 | |
| SFKSSYSVKLHYRNV | 841 | Q6ZN30 | |
| YHAAKSLYQKRGSSR | 206 | P28566 | |
| VIIHKRCVYYFKSST | 51 | P78314 | |
| TYSNKGTFRAHYKTV | 936 | Q01954 | |
| YFGIRKHLLKTNSYG | 231 | P50052 | |
| SKHIVVYHRGRYFKV | 331 | P50416 | |
| LATSYSIKYPDRVKH | 151 | Q8TB40 | |
| KKYLGSFYTDALVHD | 256 | Q8TDX5 | |
| AVYNKLRYEHTFLKS | 146 | Q9Y592 | |
| HFKRLYGKSLYSFIK | 286 | P09525 | |
| SLDYIVTYLFKHIAK | 936 | Q9H2T7 | |
| YSLIEIKLYTKHGTL | 51 | P69849 | |
| LFFHITSTRGDKYLY | 91 | Q4ADV7 | |
| DKSYRIIYNLFHKTV | 471 | Q7Z3E1 | |
| LYHKGIASAKTYYRD | 306 | O00255 | |
| KYKHYIVLLASASTE | 371 | Q9NRJ5 | |
| TLEFSKLGYIGKLYH | 251 | Q9UBM8 | |
| ISRKDLVDYITTHYK | 221 | O75439 | |
| SSKLKTYYVFGRHDI | 1101 | Q15058 | |
| YSLIEIKLYTKHGTL | 51 | Q5JPE7 | |
| YTKRISSSSYHVGDK | 381 | O43300 | |
| KDYITFIEGRSYHIT | 196 | Q6ZWT7 | |
| TQYTVKRTYAFGEKH | 51 | Q8NI17 | |
| LYSTSHGFYEEEVKK | 31 | Q9NTX5 | |
| EGIGKSLKYYRDTYH | 1286 | Q03001 | |
| YGHKRLSYQTVFLAL | 51 | Q96N19 | |
| GVTDLYYILKHSKES | 96 | O43679 | |
| QKSVFSKYFERHGYR | 306 | O95786 | |
| SETFHGFYKSTYRTK | 156 | Q9NZ08 | |
| VKVYEKYGYHISKTS | 476 | Q6PCE3 | |
| FYSHYVDKRLAGLTL | 126 | P35408 | |
| SFRDHTFLYEKLYTG | 26 | Q9UKR5 | |
| DPILYYHLSKAFRSK | 281 | O14626 | |
| YSLIEIKLYTKHGTL | 51 | Q15155 | |
| KRHSQGTFTSDYSKY | 51 | P01275 | |
| KGVKAFHVLSTDYSY | 111 | Q6JVE6 | |
| RSGIAYILHLKSYDV | 951 | P98164 | |
| KLAYEGVSSRKTYFS | 431 | Q86UT6 | |
| GRTLYYAKDSKSLIF | 91 | Q86XP1 | |
| HKLKYENYTSSFFIR | 216 | P29460 | |
| SFYKHILGKSVRYTD | 4131 | Q7Z6Z7 | |
| IYAVHLKKSGYVFFE | 191 | A8MWY0 | |
| KGIVFHYRAISTRYT | 151 | P16112 | |
| YSLRERKGHAYKEVS | 181 | Q9NQV7 | |
| VAKLTGHSYRVLYLA | 436 | Q9UM11 | |
| KFHYKKEGTYSIGTV | 36 | Q9BSB4 | |
| YNIKAIKLSRHSYFS | 286 | Q8WZ79 | |
| YIKKHFSATLAYTKL | 701 | Q14185 | |
| YKHFSATLAYVKLSK | 721 | Q9H7D0 | |
| GLESHLRSYVKYAYK | 906 | Q9BZ29 | |
| VYKTGVTHYFSLEKA | 316 | Q8WUS8 | |
| TEGKRYRIYHLATSK | 3001 | P51587 | |
| YRIYHLATSKSKSKS | 3006 | P51587 | |
| IVFPYSYTRSKSKDH | 316 | Q96IY4 | |
| SGLKYVQHTYRTGVK | 121 | P52566 | |
| FHILEYYDKTLSSKI | 1476 | Q5THR3 | |
| VKHVGSRLYSVSYLL | 2606 | P21333 | |
| TIVFLYSLYKEGHTK | 771 | Q12873 | |
| YLKLGYVSRYHVKDS | 446 | O15371 | |
| GKSYRLKHGLTTYKI | 696 | O75128 | |
| LELAHRYFSYLSKVG | 786 | Q6PD62 | |
| RKGIYSFSFHVIKVY | 116 | Q9NTU7 | |
| YLARHKGTYLTNEAK | 391 | Q8N3J6 | |
| SDHELTKKLYKRYAF | 906 | Q6IQ26 | |
| DLVLKSSVYFKHSYE | 21 | O43462 | |
| YGVLGTKELLHRTYK | 801 | Q16760 | |
| SLSLIFYYSKKGRRS | 996 | Q9UEF7 | |
| GSFHYKDKLYRSASQ | 36 | Q8IYD9 | |
| TKYHSDEYIKFLRSI | 66 | Q92769 | |
| TAVFLYSLYKEGHSK | 761 | Q14839 | |
| GETFLHTNYSLKYKL | 161 | O75462 | |
| VKKRYYDRVTGVSSF | 641 | Q8IY37 | |
| ASALGYLHSIKIVYR | 271 | Q96BR1 | |
| YYEHVKARFKRFGSA | 121 | Q9BV36 | |
| GARFHTSYDKRYIIK | 131 | P48426 | |
| SHRLSVYRKYDLKGS | 201 | P48426 | |
| GEFKFILYYQDHSTK | 276 | Q6ZNG9 | |
| YGALEHIKSYDKITV | 831 | Q8TB24 | |
| RSKKYLYQHFAEVSL | 151 | Q3ZCT8 | |
| YTHLYKTLFKLHAGA | 581 | Q8WTT2 | |
| VHYGRTSFIYLKPKS | 251 | P0C629 | |
| KRLKIFFSSADGYHL | 1421 | Q7Z2Y5 | |
| IHRQYIYFLSSKETK | 1376 | Q5TCS8 | |
| GSLALFYRKVYHLAS | 786 | P28749 | |
| YLVLHTAKTSRGFTY | 46 | Q9Y6U3 | |
| GTHVTYRKDTRYKLL | 66 | Q96D42 | |
| YSLRERKGHAYKEIS | 181 | Q9NQW5 | |
| HKIYLSTSSSKFYDL | 281 | Q9BYZ6 | |
| VESELLKGYSKYLSH | 311 | Q8IZM9 | |
| YKSALDYTKRSLGIF | 1046 | Q8TE82 | |
| YSIEGKDTHYFVKIG | 2611 | Q9NT68 | |
| HRIYLATSSSKFYDL | 281 | O94844 | |
| FTYETLKSLHREYSG | 206 | Q86VD7 | |
| SGKTYHAIQKYFSAK | 211 | Q8IYB8 | |
| LYLSKAIHKSYLDVS | 326 | Q96P15 | |
| KRTFSYYADKHETKL | 1171 | Q86SQ0 | |
| SKHIREIFGYDRKKY | 616 | Q68D10 | |
| LVHGYIVFYSAKRKA | 851 | Q9NRY4 | |
| KAKRLFRHYTVGSYD | 626 | Q9Y566 | |
| VTYHFTYGETGKRLS | 41 | Q6EIG7 | |
| PHLKTERKYYIDSSS | 1696 | Q17RW2 | |
| NHVYRRSLGKYTDFK | 201 | Q7Z4H8 | |
| VHTGERSYNYKKSRK | 806 | Q8NHY6 | |
| THYYSVKKTFLGVGQ | 191 | P17643 | |
| GVYHREARSGKYKLT | 36 | P98066 | |
| KGFYQSSIHSKYKRI | 496 | Q5SXM1 | |
| SSIHSKYKRIYTGEE | 501 | Q5SXM1 | |
| KRFTEYSSLYKHHVV | 396 | P52747 | |
| STLRTHKDYVKALAY | 111 | Q8TAF3 | |
| SFQKVTLSRYGKYGH | 31 | P52744 | |
| SKKYGVDLIRYTHAA | 61 | Q6UXN9 | |
| TDSKTHYKSGSRYEK | 211 | O75494 | |
| LKEHYLTFEKSRYET | 696 | Q9BQI7 | |
| YTSYKEKSIFLVAHR | 131 | Q15005 | |
| LIKERKIYHTGEGYF | 171 | Q6ZVD7 | |
| GQKSRASIKHDIYSY | 201 | O43353 | |
| SVEKYKKYAHSGSRD | 681 | Q96N46 | |
| TLSYYVDKHETKLKG | 1286 | Q86UU1 | |
| TYIRLYGRKFSKEDH | 81 | Q14997 | |
| YFLATQYHGRKGTVK | 231 | Q9UI43 | |
| DTERKYHLRYYKTGT | 106 | Q9H9P5 | |
| AFKYSYTLTTHKRIH | 321 | Q68DY1 | |
| GRYSLTYIYTGLSKH | 26 | P25311 | |
| KTKTSGIIEALHRYY | 316 | Q96AP4 | |
| ISREKYHTYASTGKS | 81 | A0A0C4DH27 | |
| YHTYASTGKSLKFIL | 86 | A0A0C4DH27 | |
| SKFSLHYLRKISTYV | 26 | Q9NVR7 | |
| GTRVLSLVLFYKAYH | 191 | Q6UX68 | |
| FEKIYKYLSSVSRSG | 206 | Q13487 | |
| TYKHSSKLIDRVYKG | 86 | P35125 | |
| VHKRGIYKDSYGASS | 1356 | P35573 | |
| KAYEITYVRLKFHTS | 126 | Q9Y6N6 | |
| KKRFDHSEIYTYIGS | 36 | O43795 | |
| FQSLGLYSTKHSKLY | 381 | Q8NEV4 | |
| LYSTKHSKLYIGSKR | 386 | Q8NEV4 | |
| DAVITYIKDHGLYTK | 221 | Q96T66 |